Historically Discounted RTI Surgical Transitioning To Pure Play Spine Competitor With Significant Upside

RTI Surgical (RTIX, now SRGA) is on the precipice of a transformation due to the divestiture of its OEM business to Montagu Private Equity. This divestiture can be viewed as the culmination of several years’ work to simplify the business by its relatively new CEO, Camille Farhat, as well as the beginning of an exciting transition to a pure-play high margin growing spine company and hopefully, the accompanying valuation. At 1035 Capital, we have followed SRGA since Farhat was hired as CEO and waited for this kind of catalyst to make SRGA a really exciting opportunity.

Read more on Seeking Alpha